SAPPORO MEDICAL UNIVERSITY;SUMITOMO DAINIPPON PHARMA CO., LTD.
发明人:
申请号：
EP09822007.2
公开号：
EP2363468B1
申请日:
2009.10.19
申请国别(地区):
EP
年份:
2014
代理人:
摘要：
Disclosed is a peptide consisting of the identical amino acid sequence or a substantially identical amino acid sequence to the amino acid sequence depicted in SEQ ID NO:4, wherein the peptide binds to an HLA antigen and is recognized by cytotoxic T cells. The peptide of the present invention can be used in vivo or in vitro as an agent for inducing CTL, that is, cancer vaccine, and exerts therapeutic or ameliorating effects on tumors such as osteosarcoma, renal cancer, and others. The peptide of the present invention is also useful as a tumor marker directed to tumors such as sarcoma, renal cancer, and others.
